rs746102997
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000532.5(PCCB):c.562G>A(p.Gly188Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000532.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCCB | NM_000532.5 | c.562G>A | p.Gly188Arg | missense_variant | 6/15 | ENST00000251654.9 | NP_000523.2 | |
PCCB | NM_001178014.2 | c.622G>A | p.Gly208Arg | missense_variant | 7/16 | NP_001171485.1 | ||
PCCB | XM_011512873.2 | c.562G>A | p.Gly188Arg | missense_variant | 6/11 | XP_011511175.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251438Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135894
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460686Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 726776
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74302
ClinVar
Submissions by phenotype
Propionic acidemia Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 14, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 16, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 04, 2019 | Variant summary: PCCB c.562G>A (p.Gly188Arg) results in a non-conservative amino acid change located in the Acetyl-coenzyme A carboxyltransferase, N-terminal domain (IPR011762) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251438 control chromosomes (gnomAD). c.562G>A has been reported in the literature in multiple individuals (compound heterozygotes or homozygotes) affected with Propionic Acidemia (Perez_2003, Desviat_2006, Kraus_2012, Gallego-Villar_2012, Cappuccio_2016, Tummolo_2018). These data indicate that the variant is very likely to be associated with disease. In vitro study showed that this variant had residual activity at 13% of WT levels (Gallego-Villar_2012). Two ClinVar submissions from other clinical diagnostic laboratories (evaluation after 2014) cite the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 188 of the PCCB protein (p.Gly188Arg). This variant is present in population databases (rs746102997, gnomAD 0.007%). This missense change has been observed in individuals with propionic acidemia (PMID: 12559849, 22033733, 23053474, 27900673). ClinVar contains an entry for this variant (Variation ID: 558327). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PCCB protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects PCCB function (PMID: 23053474). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at